Masimo sues US Customs over approval of Apple Watch imports

Masimo, a medical monitoring technology company, filed a lawsuit against US customs and border protection on Wednesday on a decision that allowed Apple to import Apple hours with Apple reading technology during the patent dispute between companies.

In the case of Masimo, Washington, DC, the Federal Court said that customs, Apple could import watches with pulse oximeter technology and that it could reverse its own decision without notifying Masimo last year.

Masimo told the court that the Agency had learned the August 1 decision, but after Apple announced that it would restart the blood oxygen reading last week.
Apple and Customs Spokesman did not immediately respond to comments. A Masimo spokesman refused to comment.

Masimo Irvine, based in California, accused Apple of hiring its employees and using pulse oximeter technology at Apple times. Masimo filed a lawsuit against Apple for a patent violation and trade secret theft in the ongoing federal court cases.

Masimo convinced the US International Trade Commission to prevent Apple’s blood oxygen levels to prevent the import of Apple’s 9 and Ultra 2 smart watches in 2023 based on the determination of reading Masimo’s patents of Masimo. Apple has continued to sell customs -approved hours without a pulse oximeter since ITC’s decision. Apple said that on August 14, smart watches will restart the blood-oxian reading capabilities with the approval of customs. Masimo said that the agency entered Masimo or that the decision of approval of any “meaningful justification” without input is deprived of the company’s rights. “The function of the CBP is not to implement ITC exclusion orders, to create gaps that neutralize them.” He said.

Masimo asked the Washington Court to continue to prevent the agency to stop the decision and to prevent Apple from selling hours with blood oxygen.